Acuta Capital Partners as of Dec. 31, 2023
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 39 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rayzebio | 13.2 | $24M | 378k | 62.17 | |
| Cymabay Therapeutics | 6.5 | $12M | 492k | 23.62 | |
| Rocket Pharmaceuticals (RCKT) | 6.2 | $11M | 366k | 29.97 | |
| Kura Oncology (KURA) | 5.7 | $10M | 701k | 14.38 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 5.5 | $9.8M | 425k | 23.11 | |
| Vaxcyte (PCVX) | 4.1 | $7.4M | 117k | 62.80 | |
| Sarepta Therapeutics (SRPT) | 3.8 | $6.8M | 71k | 96.43 | |
| Praxis Precision Medicines I (PRAX) | 3.8 | $6.7M | 300k | 22.28 | |
| Disc Medicine (IRON) | 3.8 | $6.7M | 116k | 57.76 | |
| Taysha Gene Therapies Com Shs (TSHA) | 3.6 | $6.4M | 3.6M | 1.77 | |
| Miragen Therapeutics (VRDN) | 3.5 | $6.1M | 282k | 21.78 | |
| Tourmaline Bio (TRML) | 3.4 | $6.1M | 232k | 26.18 | |
| Ocular Therapeutix (OCUL) | 3.3 | $5.8M | 1.3M | 4.46 | |
| Mersana Therapeutics (MRSN) | 3.1 | $5.5M | 2.4M | 2.32 | |
| Hillevax (HLVX) | 2.9 | $5.2M | 325k | 16.05 | |
| Immunovant (IMVT) | 2.8 | $5.0M | 120k | 42.13 | |
| Revolution Medicines (RVMD) | 2.6 | $4.6M | 160k | 28.68 | |
| Apellis Pharmaceuticals (APLS) | 2.6 | $4.6M | 76k | 59.86 | |
| Arcellx Common Stock (ACLX) | 2.4 | $4.3M | 77k | 55.50 | |
| Aadi Bioscience (AADI) | 2.1 | $3.7M | 1.8M | 2.02 | |
| Terns Pharmaceuticals (TERN) | 2.0 | $3.6M | 555k | 6.49 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.8 | $3.1M | 88k | 35.58 | |
| Celldex Therapeutics Com New (CLDX) | 1.5 | $2.8M | 69k | 39.66 | |
| An2 Therapeutics (ANTX) | 1.5 | $2.7M | 132k | 20.49 | |
| Dyne Therapeutics (DYN) | 1.1 | $2.0M | 148k | 13.30 | |
| Verastem Com New (VSTM) | 1.1 | $1.9M | 232k | 8.14 | |
| Applied Therapeutics (APLT) | 1.0 | $1.8M | 525k | 3.35 | |
| Enliven Therapeutics (ELVN) | 1.0 | $1.7M | 124k | 13.84 | |
| 4d Molecular Therapeutics In (FDMT) | 0.8 | $1.5M | 75k | 20.26 | |
| Leap Therapeutics Com New (LPTX) | 0.8 | $1.5M | 354k | 4.14 | |
| Cellectar Biosciences Com New (CLRB) | 0.7 | $1.3M | 478k | 2.77 | |
| Insmed Com Par $.01 (INSM) | 0.5 | $914k | 30k | 30.99 | |
| Argenx Se - Sponsored Adr (ARGX) | 0.5 | $913k | 2.4k | 380.43 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.2 | $378k | 19k | 19.88 | |
| Springworks Therapeutics (SWTX) | 0.2 | $365k | 10k | 36.50 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $304k | 38k | 7.96 | |
| Tyra Biosciences (TYRA) | 0.1 | $123k | 8.9k | 13.85 | |
| Anavex Life Sciences Corp Com New Put Option (AVXL) | 0.0 | $23k | 1.0k | 22.50 | |
| Nuvation Bio *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $5.4k | 91k | 0.06 |
